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Abstract 
Pregnancy is considered a unique immune challenge in that the mother has to 
suppress rejection responses against the fetus whilst maintaining her resistance to 
infection. Innate immunity has a particularly important role in overall maternal 
immune defense during pregnancy, abnormal innate activity is associated with 
pregnancy-specific disorders, such as recurrent pregnancy loss, intrauterine growth 
retardation and preeclampsia. Lectins are pattern recognition proteins involved in 
lectin-complement pathway for humoral innate immunity. There is no literature 
studying the pattern recognition lectins in pregnancy. It is unknown where, when and 
how the lectins are maintained during normal and abnormal pregnancy. 
In the first part of the study, normal pregnant mice were used as model to study 
the expression of pattern recognition lectins in maternal liver and lung, endometrium 
and maternal-fetal interface. The results showed that expression of lectins in 
endometrium was not associated with that in maternal liver and lung during and after 
pregnancy. High expression of lectins in endometrium in early pregnancy became 
specific in trophoblastic and decidual cells throughout the gestation, suggesting 
lectins are required for normal placentation and decidualization during pregnancy. 
i 
This interaction between mother and fetus in maternal-fetal interface may contribute 
to the physiological innate immune response in maintaining the normal pregnancy. 
In the second part of the study, the expression of pattern recognition lectins in 
placentae and/or deciduae in preeclamptic and miscarriage pregnancies was 
investigated. In preeclamptic women, the co-expression of lectins and apoptotic 
protein Fas in cytotrophoblastic cells undergoing apoptosis indicated unique 
involvement of lectins in preeclamptic placentae, anticipating in specific-binding and 
clearance of apoptotic trophoblasts and resulting in local innate immunity responses. 
In spontaneous miscarriage, both placental and decidual lectins in trophoblastic, 
decidual and glandular epithelial cells were increased when compared with 
gestational-age matched controls. The over-expression of lectins in maternal fetal 
interface in miscarriage, a complication of early pregnancy, suggested a common 
pathological lectin-complement pathway and innate immune response as in 
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The immune system allows organisms to distinguish between self and foreign 
substances and protects the host against infections and diseases through a collection 
of mechanisms. It involves two defensive components, the adaptive immunity and 
the innate immunity. 
In contrast to innate immunity, the adaptive immune system is specific with 
immunological memory built response and there is a lag time between exposure to 
foreign substances and the adaptive response. 
Though no immunological memory is built, innate immune system offers 
immediate response and is the first line of defence against infection. Mechanisms 
of the innate immune system involve in eliminating invading pathogens through 
surface barriers, cell-mediated functions and humoral functions (Aagaard-Tillery et 
al.，2006). 
1 
1.1.1 Surface Barriers 
Skin covering the whole surface of the body is a classical example of 
mechanical barriers (Goodarzi et al.，2007; Ohashi et al., 2006). Mucosal lining of 
the respiratory and gastrointestinal tracts also acts as physical barrier that can 
efficiently trap microorganisms (Nochi and Kiyono, 2006). In addition to 
mechanical barriers, chemical barriers also protect the host against infections. 
Antimicrobial peptides such as defensins secreted by skin, respiratory, alimentary 
and genitourinary tracts have anti-bacterial, anti-fungal and anti-viral activities 
(Abiko et al., 2003; Huttner and Bevins, 1999). Fatty acids in sweat and gastric 
secretion in stomach are able to inhibit bacterial growth, whereas lysozyme and 
phospholipase in saliva, tears and nasal secretions can lyse the cell wall of bacteria 
(Drake et al., 2008; Kmiliauskis et al” 2005). Apart from the mechanical and 
chemical barriers, commensal bacteria of the host can serve as biological barriers to 
prevent colonization of pathogenic bacteria (Magalhaes et al., 2007). 
1.1.2 Cell-mediated Innate Immunity 
Phagocytic cells, mast cells and natural killer (NK) cells are major cellular 
components of the innate immune system (Kapetanovic and Cavaillon, 2007). 
Phagocytes include macrophage (the precursor of monocytes), dendritic cells and 
2 
granulocytes. Pathogens and cell debris are engulfed and destroyed by phagocytic 
cells in the process of phagocytosis. Besides, phagocytosis induces inflammation 
response. Macrophages and dendritic cells also present antigens to T helper cells 
in cytokine release (Ureta et al., 2007). Mast cells release histamine and also 
cytokines and chemokines that are involved in inflammatory reaction 
(Krishnaswamy et al., 2006). NK cells are able to produce cytotoxic 
proinflammatory cytokines that they kill pathogens by apoptosis. On the other 
hand, NK cells can be activated by cytokines or direct bind to pathogens (Korbel et 
al., 2004). 
1.1.3 Humoral Innate Immunity 
The complement system and the pattern recognition molecules are involved in 
humoral functions of innate immunity (Kemper and Atkinson, 2007; Holmskov et 
al., 2003). Upon activation, complement helps clear the pathogens by promoting 
opsonization and phagocytosis. Complement also induces cytokine release and cell 
lysis (Rus et al., 2005). A series of pattern recognition molecules can recognize 
and bind pathogen-associated molecular patterns (PAMP) on the surfaces of 
pathogens (Holmskov et al” 2003; Visser et al., 2007). Such as Toll-like receptors, 
nucleotide-binding oligomerization domain and pattern recognition lectins allow 
3 
pathogens to be recognized and thereby trigger the innate immune chain reactions 
(Guan and Mariuzza, 2007). 
1.2 Complement System 
Complement is a part of the innate immune system that activates the 
leukocytes and enhances phagocytosis. More than 35 interacting proteins are 
involved (Thiel, 2007). Complement can be triggered through three pathways, 
including the classical, alternative and lectin pathways. The classical pathway is 
involved in adaptive immune system while the alternative and the lectin pathway are 
involved in innate immune system. When the complement system is activated, a 
series of reactions take place resulting in the formation of C3 convertase and 
membrane attack complex (MAC) for the destruction of intruding pathogens by 
inducing cell lysis (Stehle and Larvie, 2003). 
Regardless of the ways of pathway activation, the complement system proceeds 
along the same path after generating the C3 convertase. A cascade of events 
including phagocytosis, recruitment of inflammatory cytokines and formation of 
MAC is then triggered to help with the elimination of pathogenic intruders. 
4 
1.2.1 The Classical Pathway 
The classical pathway is initiated when Clq of the first complement component 
(CI) binds to the antibody-antigen complexes (Figure 1.1). Activated CI can then 
cleave C4 into C4a and C4b, and cleave C2 into C2a and C2b respectively, leading 
to the formation of classical C3 convertase (C4b2a) (Gadjeva et al.，2003). C3 
convertase in turn converts C3 into C3a and C3b. Both C3b and C4b can act as 
opsonins and enhance phagocytosis. In addition, classical C5 convertase (C4b2b3b) 
is formed. C5 is converted into C5a which is an inflammatory peptide, and C5b 
which activates the lytic pathway. 
Immunog l obu l i n^ C ) ^ — ~ ^ ^ 
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Figure 1.1. The classical pathway. 
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1.2.2 The Alternative Pathway 
The alternative pathway is initiated by the spontaneous tickover of C3 
(Pangburn and Muller-Eberhard, 1986) (Figure 1.2). Spontaneous tickover leads to 
conformational change in C3 to become C3(H20) and allows binding to factor B. 
The shape of factor B is thereby changed and serum protease factor D can cleave the 
altered factor B into Ba and Bb (Thurman and Holers, 2006). Bb then remains part 
of the complex forming C3(H20)Bb which is a C3 convertase and cleaves more C3 
generating C3b. C3b formed binds to factor B which again is altered and cleaved 
by factor D to generate the C3 convertase (C3bBb). C3b formed in the other two 
complement pathways can also binds factor B in the same way acting as an 
amplification loop to generate the C3 convertase. In addition, C3b can bind C3bBb 
to form a C5 convertase (C3bBb3b) and thereby leads to the formation of MAC 
(Hourcade, 2006). 
\ W …………… 
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Figure 1.2. The alternative pathway. 
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1.2.3 The lectin pathway 
The lectin pathway is initiated when lectins recognize and bind to the 
carbohydrates on pathogens (Matsushita and Fujita, 2001) (Figure 1.3). Lectins are 
associated with mannose-binding lectin-associated serine proteases (MASP) and 
small mannose-binding lectin-associated protein (sMAP). Upon binding of the 
pattern recognition lectins to the carbohydrates of pathogens, associated MASPs and 
sMAP, and thus the complement system are activated. There are MASP-1, 
MASP-2 and MASP-3 while the sMAP, also known as MApl9, is a truncated form 
of MASP-2 (Schwaeble et al., 2002). MASP-1 cleaves C2 and C3 while MASP-2 
cleaves C2 and C4 leading to the formation of C3 convertase (C4b2a) and C5 
convertase (C4b2a3b) (Matsushita et al., 2000). This heads to enhanced 
phagocytosis and activation of lytic pathway for host defense. MASP-3 has been 
reported to inhibit the cleaving activity of MASP-2 while sMAP has been suggested 
to have a down-regulatory role in complement activation of the lectin pathway (Dahl 
et al , 2001;Iwaki et al., 2006). 
7 
convertQse (C4b2a) pathOgen\ 
C5 convertase (C4b2a3b) 
Figure 1.3. The lectin pathway. 
1.3 Lectins 
Lectins are carbohydrate-binding proteins. They are present in both plants 
and animals. Members of lectin are classified according to their structure and 
recognition specificity (Figure 1.4). The key biological function of lectins is to 
serve as pattern recognition molecules in innate immune system that can recognize 
and bind to the carbohydrate structures on the surfaces of pathogens and thereby 
opsonize the pathogens through phagocytosis. 
8 
Among animal lectins, there is a large group known as calcium-dependent 
(C-type) lectins. C-type lectin family is further diverged into two subfamilies, 
selectins and collectins. Nine col lectins have been identified so far. Surfactant 
protein A and D, mannose binding lectin and ficolins are representatives of 
collectins. 
Surfactant protein A and D (SP-A and SP-D) are expressed in lung and they 
promote phagocytotic activities (Kuroki et al.，2007). SP-A and SP-D are also 
expressed in female genital tract. It has been reported that SP-A was expressed in 
vagina and SP-D was expressed in uterus, cervix, placenta as well as corpus luteum 
(Leth-Larsen et al., 2004; MacNeill et al., 2004). SP-A and SP-D might play a role 
in preventing uterine infection. 
Mannose binding lectin and ficolins in human are important members of lectin 
involved in humoral innate immunity (Holmskov et al” 2003). After binding to 
pathogens, mannose binding lectin and ficolins, in association with serine proteases, 
initiate the complement system via lectin pathway in innate immunity and assist in 






































































































































































































1.3.1 Mannose binding lectin 
Mannose binding lectin (MBL), also known as mannan binding lectin, is a 
C-type lectin belongs to the collectin subfamily. MBL is synthesized in liver and it 
is a serum protein that the expression is determined by the genotypes (Megia et al” 
2004). MBL has an NH2-terminal domain, a collagen-like domain, a neck domain 
and a carbohydrate-recognition domain (CRD). Through the CRD, MBL binds to 
mannose and N-acetyl-D-glucosamine (GlcNAc) (Arnold et al., 2006). The 
binding is calcium dependent and associated with MASPs and sMAP in activation of 
complement system in the innate immunity. The blood concentration of MBL in 
healthy subjects varies from 3 ng/ml to 5 |j.g/ml. 
1.3.2 Ficolin 
Ficolins contain a fibrinogen-like (FBG) domain instead of a CRD, though 
ficolins are similar to MBL that they also consist of an NH2-terminal domain, a 
collagen-like domain and a neck domain (Endo et al., 2007). Ficolins also activate 
complement system via associated serine proteases MASPs and sMAP. They can 
act as opsonins and initiate the lectin-complement pathway of innate immunity. 
Ficolins in human consist of L-ficolin, H-ficolin and M-ficolin. 
11 
1.3.2.1 L-ficolin 
L-ficolin, also known as p35, hucolin or elastin-binding protein-37, is a lectin 
made up of 35 kDa subunits (Hummelshoj et al., 2007). It binds to sugar structures, 
GlcNAc and N-acetyl-D-galactosamine (GalNAc) via its FBG domain (Ohashi and 
Erickson, 1997). Similar to MBL, L-ficolin binds to GlcNAc in a calcium 
dependent manner (Matsushita et al., 1996). In addition, L-ficolin has been shown 
to bind S. typhmurium 丁VI19 and enhance phagocytosis. L-ficolin has also been 
shown to bind elastin and corticosteroid (Edgar, 1995; Harumiya et al., 1996). 
L-ficolin is therefore believed to have multiple functions. Human L-ficolin was 
reported to be synthesized in liver and secreted into blood circulation (Le et al., 
1998). The blood concentration of L-ficolin in healthy subjects is ranged from 
1.lug/ml to 12.8ug/ml (Kilpatrick et a l , 1999). 
1.3.2.2 H-ficoIin 
H-ficolin, also known as Hakata antigen or thermolabile |3-2 macroglycoprotein, 
is a lectin made up of 34 kDa subunits (Matsushita et al., 2002). It was first 
identified as a serum protein in systemic lupus erythematosus patients (Honore et al., 
2007). In addition to be found as a serum protein, H-ficolin was reported to be 
expressed in lung and liver and secreted into bronchus, alveolus and bile duct 
12 
(Akaiwa et al., 1999; Sugimoto et al., 1998). The serum concentration ofH-ficolin 
in healthy subjects is ranged from 7ug/ml to 23ug/ml (Yae et al., 1991). H-ficolin 
binds to GlcNAc and GalNAc. Though GlcNAc is a common ligand for both H-
and L-ficoIin, the two ficolins have been shown to have different binding 
specificities (Matsushita et al., 2002). This could be helpful for the removal of 
various microbes displaying differential carbohydrate arrays on surfaces. H-ficolin 
has also been reported bind to PSA, a polysaccharide that is produced by 
Aerococcus viridans and is made up of glucose, mannose, GlcNAc and xylose 
(Tsujimura et al., 2001). Unlike MBL and L-ficolin, binding of H-ficolin to ligands 
does not require calcium. 
1.3.2.3 M-ficolin 
M-ficoIin is also known as ficolin-1 or ficolin/p35-related protein (Matsushita 
and Fujita, 2001). Unlike the other two ficolins, M-ficolin is not a serum 
lectin. The expression of M-ficolin was found in leukocytes, lung and spleen (Liu 
et al., 2005; Lu et al., 1996). By binding to carbohydrate ligands, M-ficolin could 
also form M-flcolin-MASP complexes and activate the lectin pathway. In 
addition to the binding ability to GlcNAc and GalNAc, M-ficolin could also bind to 
sialic acid which is important for cell growth regulation, cell differentiation, cellular 
13 
communication and adhesion (Sotiropoulou et al., 2002). The detail immunological 
functions of M-ficolin remain unclear. 
Because of the differences in the recognition domain sequences, lectins bind to 
different carbohydrate ligands, which is important in offering protection against the 
large spectrum of pathogens. 
14 
Chapter 2 
Innate Immunity in Pregnancy 
2.1 Immune challenge 
Pregnancy presents as an immune challenge. The semi-allogeneic fetus has to 
be accepted, while at the same time host defences against invading pathogens has to 
be maintained (Heikkinen et al., 2003). During pregnancy, maternal specific 
immune system is relatively suppressed for the acceptance of the fetal semi-allograft. 
Changes in peripheral monocytes and granulocytes in pregnancy were found to be 
similar to the situation in patients with sepsis where innate immune response is 
activated (Sacks et al., 1998). The innate immune system is therefore believed to 
be activated in pregnancy and can compensate for the suppression of the maternal 
adaptive immune response (Sacks et al., 1999). 
2.2 Natural Antimicrobials 
As surface barrier in innate immunity, defensins are also present in amnion, 
chorion and placenta (Svinarich et al” 1997). There are two types of defensins in 
human: a-defensins and (B-defensins. Human neutrophils peptides (HNP) 1-3 of 
the a-defensins are found in amniotic fluid collected from term pregnancies (Akinbi 
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et al., 2004). Human (3-defensins (HBD) 1-3 are also found in decidua, placenta 
and fetal membranes from term pregnancies (King et al., 2007). In addition to 
defensins, secretory leukocyte protease inhibitor (SLPI), elafin and lactoferrin (LF) 
are natural antimicrobials in relation to pregnancy. These natural antimicrobials 
are important for preventing uterine infection in late pregnancy. SLPI is detected 
in decidua and amnion (King et al., 2000; Zhang et al” 2001). The concentration 
of SLPI in amniotic fluid has been shown to be significantly higher in third trimester 
than in the second trimester. The concentration is further increased at the onset of 
labour at term (Denison et al., 1999). Elafin is also detected in fetal membranes, 
decidua and placenta at term pregnancy (King et al., 2007). LF expression was 
found in amnion, chorion and decidua (Niemela et al., 1989). LF concentration in 
amniotic fluid is significantly increased at 30 weeks of gestation and remained high 
till term. Taken together, these natural antimicrobials are important immune 
system in defending late pregnancy and preparing birth. 
2.3 Cell-mediated Immunity 
Cell-mediated immunity in pregnancy is extensively studied. During 
pregnancy, total number and proportion of peripheral granulocytes are increased 
(Luppi et al., 2002b). Similar to granulocytes, number of monocytes in maternal 
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circulation is also increased. Peripheral granulocytes and monocytes are 
progressively activated with increased expression of surface markers, such as CD64 
and CD 14, which enhanced phagocytosis and increased production of intracellular 
reactive oxygen species (Luppi et al., 2002a; Naccasha et al., 2001). However, 
peripheral NK cell number and their interferon y (IFN-y) production are reduced in 
pregnant women (Veenstra van Nieuwenhoven et al., 2002). It may suggest the 
activation of innate immunity during normal pregnancy is rather selective. 
Decidua of the uterus during pregnancy is the interface between mother and 
fetus. The decidual innate immune cells are important for successful pregnancy. 
In early pregnancy, number of uterine NK (uNK) cells is significantly increased 
(Ozenci et al., 2001). The large number of uNK cells is believed to offer protection 
against infections and regulate the immunity. uNK cells produce angiogenic 
growth factors and cytokines that are involved in implantation and placentation 
(Torry et al., 2007). For example, granulocyte colony-stimulating factor, 
granulocyte-macrophage colony-stimulating factor and macrophage 
colony-stimulating factor are uNK cell-derived cytokines that promote trophoblast 
growth, proliferation and differentiation, whereas leukaemia inhibitory factor 
stimulates trophoblast growth as well as implantation (Garcia-Lloret et al., 1994; 
17 
Nachtigall et al., 1996). In contrast, transforming growth factor p prevents 
trophoblast proliferation and differentiation, whereas tumour necrosis factor-a 
(TNF-a) and IFN-y inhibit implantation and trophoblast invasion (Karmakar and 
Das, 2002; Yui et al., 1994). 
Besides uNK cells, macrophages are present in decidua and pregnant uterus 
(Khong, 1987). Invasive cytotrophoblasts of the placenta produce monocytes 
inflammatory protein (MIF)-l alpha and can attract monocytes into the decidua 
(Drake et al., 2001). Phagocytic activity of macrophages is important for effective 
removal of cell and tissue debris in pregnancy (Abrahams et al., 2004). 
Macrophages also produce cytokines, such as TNF-a, which are important for 
successful pregnancy (Singh et al., 2005). 
2.4 Humoral Immunity 
For humoral-mediated response in normal pregnancy, complements are 
activated with increased concentrations of anaphylatoxins C3a, C4a and C5a in 
maternal circulation until 20 weeks of gestation (Richani et al” 2005). On the 
other hand, the serum concentration of MBL is increased during pregnancy (van de 
Geijn et al., 2007). The increase has been observed at 12 weeks of gestation and 
18 
remained throughout the pregnancy. Serum MBL concentration at 6 week 
post-partum is then significantly decreased. Apart from these, humoral immunity 
in pregnancy is not fully characterized. The elevations of complements and MBL 
in early and mid gestations may indicate its role in maintaining successful pregnancy. 




Humoral innate immunity in pregnancy is not fully studied. As the key 
pattern recognition molecules in lectin pathway, lectins may significantly contribute 
innate immunity during pregnancy. However, expression of lectins and their role in 
normal and abnormal pregnancy remain largely unknown. Open questions remain 
if the secretion of lectins changes upon pregnancy, if the lectins are expressed in the 
female reproductive tract, if their expression changes in implantation, 
decidualization and placentation, and if the lectins play a role in abnormal 
pregnancies, eg. preeclampsia and miscarriage. 
3.1 Aim and Objectives 
The aim of the study is thus to understand the expression and the role of pattern 
recognition lectins in normal and abnormal pregnancies. The study objectives are: 
1. to study the expression of pattern recognition lectins in maternal liver and lung 
before, during and after pregnancy; 
2. to study the expression of pattern recognition lectins in endometrium before, 
during and after pregnancy; 
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3. to study the expression of pattern recognition lectins in the maternal-fetal 
interface during early, mid- and late pregnancy; and 
4. to study the role of pattern recognition lectins in preeclampsia and miscarriage. 
3.2 General Methodology 
Mouse was used as a model to study the expression of pattern recognition 
lectins in maternal liver and lung (Chapter 4)，and endometrium (Chapter 5) before, 
during and after pregnancy, and also their expression in maternal-fetal interface 
(Chapter 6) during normal pregnancy in early decidualization and placentation. 
Human placenta or deciduae were used to study the possible role of pattern 
recognition lectins in preeclampsia (Chapter 7) and miscarriage (Chapter 8). 
Mainly, Western blot and immunohistochemistry analyses were employed to 
study the temporal and spatial protein expression of pattern recognition lectins in 
this study. Immunohistochemistry is a method to localize specific proteins in a 
biological tissue section. It involves specific antigen-antibody interaction. Tissue 
section is probed with primary antibody that specifically binds to the protein of 
interest and localization of the target protein is visualized by using labeled 
secondary antibody. Western blot is a method to detect a specific protein level in a 
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biological lysate. Through gel electrophoresis, it separates proteins by their 
molecular weight. The proteins are then transferred to a membrane and probed 
with primary antibody specific to the target protein to be studied. Detection of 




Pattern recognition lectins in maternal liver and lung 
4.1 Introduction 
Liver and lungs are major lectin producing sites. Ficolins and MBL are 
mainly synthesized in liver. Synthesis of H-ficolin in lung has also been shown. 
It is yet unclear if their expression in maternal liver and lung change in normal 
pregnancy. In this chapter, expression of lectins in maternal livers and lungs before, 
during and after pregnancy was studied. Mouse maternal livers and lungs were 
collected for the study, as it is practically and ethically not possible to obtain biopsy 
from healthy pregnant women. Western blot and immunohistochemistry using 
antibodies against lectins were used to characterize the temporal and spatial 
expression of lectins respectively. 
4.2 Materials and Methods 
4.2.1 Animals 
Female inbred immune competent Institute of Cancer Research (ICR) mice, 
supplied by the Laboratory Animal Services Centre (LASEC) of the Chinese 
University of Hong Kong, were used for the study. Non-pregnant adult ICR, 
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pregnant mice at embryonic day 2 to 18 (E2 to El8) and postpartum mice at day 0 to 
7 (PO to P7) were obtained. Overnight mating was performed and vaginal plug was 
checked in the next morning for successful mating. Fertilization at midnight was 
assumed and regarded as embryonic day 0 (EO). The mice were sacrificed and 
non-pregnant (NP), early pregnant (E2 and E5) and postpartum (PO) maternal livers 
(Figure 4.1) and lungs (Figure 4.2) were collected. Plasma of maternal blood was 



























































































































































































































































































4.2.2 Protein extraction 
Maternal livers and lungs at different gestational stages were collected, snap 
frozen in liquid nitrogen and stored at -80 ®C until used. Each maternal liver or 
lung was lysed and homogenized in RIPA buffer (50 mM Tris-HCl, 150 mM NaCI, 
1 mM PMSF, 1 mM EDTA, 1 % SDS, 1 % NP40) with a handheld homogenizer. 
Lysate was then centrifuged at 14000 rpm for 10 min at 4 °C and supernatant was 
transferred into a clean tube. Total protein concentration in supernatant was 
measured using detergent compatible (DC) protein assay kit (Bio-rad Laboratories, 
California). The DC protein assay is a colorimetric assay for protein concentration 
and the absorbance was measured and quantified at 750 nm. 
4.2.3 Antibodies 
There is only one form of MBL protein found in human. However, MBL 
occurs in two forms termed MBL-A and MBL-C proteins in mouse (Hansen et al., 
2000). Human MBL and the two mouse MBL forms share about 60% sequence 
identity (Holmskov et al., 2003). Both mouse MBL-A and MBL-C were able to 
activate the lectin pathway (Trouw et al., 2005). For ficolins, there are L-, H- and 
M-Ficolin proteins in human. But in mouse, there are only two ficolin forms 
named Ficolin-A and Ficolin-B (Runza et al., 2008). Mouse Ficolin-A was 
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reported to activate the lectin pathway. Herewith primary antibodies against mouse 
MBL-A, MBL-C, Ficolin-A and Ficolin-B were used in mouse studies. 
4.2.4 Western Blot 
A hundred microgram total protein of lysate from each maternal liver or lung 
sample was mixed with 3X Laemmli loading dye and boiled at 95 for 5 min. 
Samples were then subjected to sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) and proteins were separated by molecular weight. 
Broad range prestained SDS-PAGE standards (Bio-rad Laboratories, California) 
were run on the same gel as a reference for the protein size. After separated by 12 
o/o separating gel at 35 mA at room temperature, proteins were transferred onto 
nitrocellulose membranes (Amersham, Buckinghamshire) at 300mA at 4 The 
membranes were then washed at room temperature (RT) with IX Tris buffered 
saline (TBS) and 0.05 % Tween 20 for five times, and rotated for 3 min. The 
membranes were incubated with blocking solution (5 % non fat milk in IX 
TBS-Tween 20) at 37 for 30 min. The membranes were then incubated with 
rabbit anti-mouse Ficolin-A (1:1000 dilution; University of Regensburg, Germany), 
rabbit anti-mouse Ficolin-B (1:2000 dilution; University of Regensburg, Germany), 
rat anti-mouse MBL-A (clone 13H6; 1:1000 dilution; Aarhus University, Denmark) 
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or rat anti-mouse MBL-C (clone 18D8; 1:1000 dilution; Aarhus University, 
Denmark) primary antibody diluted in blocking solution at 4 overnight. After 
incubated with the primary antibodies, the membranes were again washed five times 
with IX TBS-Tween 20 at RT. For anti-Ficolin-A and anti-Ficolin-B antibodies, 
membranes were then incubated with anti-rabbit IgG horseradish peroxidase (HRP) 
secondary antibody (Amersham, Buckinghamshire) diluted 1:1000 in IX TBS for 60 
min at RT. For anti-MBL-A and anti-MBL-C antibodies, anti-rat IgG-HRP was 
used as the secondary antibody. Five washes with IX TBS-Tween 20 were then 
performed and the membranes were incubated with ECL™ Western blotting 
detection reagents (Amersham, Buckinghamshire) for film development. 
4.2.5 Immunohistochemistry 
Maternal livers and lungs collected at different gestational stages were fixed in 
4% paraformaldehyde solution at 4 °C overnight. Tissues were processed and 
embedded in paraffin blocks. Five-jim-thick tissue sections were prepared and 
mounted onto 3-aminopropyl-triethoxysilane (Sigma-Aldrich, St. Louis) coated 
slides. Tissue sections were deparaffinized in xylene and rehydrated to distilled 
water. Tissue sections were stained with haematoxylin and eosin (H&E) for 
histological examination. Other sections were stained with rabbit anti-mouse 
2 9 
Ficolin-A (1:100 dilution), rabbit anti-mouse Ficolin-B (1:100 dilution), rat 
anti-mouse MBL-A (1:200 dilution) or rat anti-mouse MBL-C (1:200 dilution) 
primary antibody for immunohistochemical analysis. Sections were then incubated 
in boiled sodium citrate buffer solution (lOmM sodium citrate, 0.05% Tween 20, pH 
6.0) for 30 minutes at RT. After antigen retrieval, sections were washed with IX 
phosphate buffered saline (PBS). Sections were then incubated in 3% hydrogen 
peroxide solution in methanol for 30 min in dark, followed by IX PBS washing at 
RT. Sections were incubated with the blocking solution (5% goat serum, 5% 
bovine serum albumin in IX PBS) for 30 min at RT. The blocking solution was 
then removed and the sections were incubated with individual primary antibody 
diluted in blocking solution at 4 overnight. Sections incubated with blocking 
solution with no primary antibody were used as negative control. After incubating 
with primary antibodies, sections were washed with IX PBS at RT, followed by 
secondary antibodies incubation. For anti-MBL-A and anti-MBL-C antibodies, 
goat anti-rat IgG-HRP secondary antibody (Santa Cruz Biotechnology Inc., CA) 
1:1000 diluted in IX PBS was used; while for anti-Ficolin-A and anti-Ficolin-B 
antibodies, MACH 3 rabbit HRP polymer kit (Biocare medical, Concord) was used 
as secondary antibody. After incubating with secondary antibodies at RT, sections 
were washed with IX PBS and undergone colour development with Cardassian 
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3,3 '-diaminobenzidine tetrahydrochloride (DAB) Chromogen Kit (Biocare medical, 
Concord) at RT. Sections were then counterstained with 1% methyl green solution. 
Sections were dehydrated and mounted with DPX mounting medium 
(Sigma-Aldrich, St. Louis) at last. Histological sections were examined under a 
light microscope (Leica Microsystems GmbH, Germany). 
4.3 Results 
4.3.1 Temporal expression of lectins in maternal liver in mice 
In Western blot analysis, expressions of mouse Ficolins and MBLs were 
detected in maternal liver lysate. Their expression levels were higher at 
postpartum stage than during pregnancy (Figure 4.3). In postpartum, the 
expression level of Ficolin-B was slightly higher than Ficolin-A, while the 
expression level of MBL-C was also slightly higher than MBL-A. During 
pregnancy, the expressions of Ficolin-A and MBL-A were very low, however. The 
expression of the lectins before pregnancy was similar to that during pregnancy and 
there was no detectable change throughout pregnancy. 
4.3.2 Temporal expression of lectins in maternal lung in mice 
The Western blot analysis of lectins in maternal lung was not very successful. 
31 
The total protein content in each maternal lung was less than 25 |ig, which is not 
enough for Western blot analysis. Additional maternal lung tissues were collected 
and pooled in attempt to increase total protein content to around 100 |ig，but the 
antibodies used was not sensitive enough to react with the lectins in the maternal 



































































































































































































































































4.3.3 Spatial expression of lectins in maternal liver in mice 
Figure 4.4 showed the histology and immunohistochemistry of mouse lectins in 
maternal liver before, during and after pregnancy. Slightly fatty change of 
maternal liver during pregnancy was observed but this is within normal 
physiological change during pregnancy in both mouse and human. 
Hepatocytes and bile duct epithelial cells were positively stained with 
anti-Ficolin-A and anti-Ficolin-B antibodies. In non-pregnancy and pregnancy 
states, Ficolin-A and Ficolin-B positively stained hepatocytes were distributed 
mainly near central vein; while at postpartum stage, most of the hepatocytes in 
hepatic nodule were positively stained. As in Western analysis, the expression 
levels of Ficolin-A and Ficolin-B before pregnancy were similar to that in pregnancy, 
but their expression levels were increased after delivery. And also the expression 
level of Ficolin-B was higher than that of Ficolin-A. 
MBL-C, but not MBL-A, was positively stained in hepatocytes only. In 
immunohistochemical analysis, the expression levels of MBLs were very low when 
compared with that of Ficolins. The expression levels of MBLs before, during and 
after pregnancy were similar. No obvious increase in MBL expressions was 
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observed at postpartum stage as in Ficolin expressions. In non-pregnancy, MBL-C 
positively stained hepatocytes were mainly near central vein region; while in 
pregnancy and at postpartum stage, peripheral hepatocytes were positively stained. 
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Figure 4.4. Spatial expression of lectins in maternal liver. H&E and 
immunostaining of lectins in maternal livers in mice before (left panel), during 
(middle panel) and after (right panel) pregnancy are shown. Hepatocytes (in blue 
arrows) or bile duct epithelium (in red arrows) positively stained with Ficolin-A, 
Ficolin-B and MBL-C are indicated. Images are at 200x magnification, cv: central 
vein; bd: bile duct. n=2, the representing sections from NP, El2.5 and PO are 
presented. 
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4.3.4 Spatial expression of lectins in maternal lung in mice 
Figure 4.5 showed the histology and immunohistochemistry of mouse lectins in 
maternal lung before, during and after pregnancy. Ficolin-A and Ficolin-B were 
positively stained in bronchiolar epithelium and alveolar wall of maternal lung. As 
in maternal liver, the expression levels of Ficolins in maternal lung were higher than 
that ofMBLs. 
The expression level of Ficolin-A was similar to that of Ficolin-B. Their 
expression levels were similar in non-pregnancy and during pregnancy, but were 
increased in bronchiolar epithelium after delivery. 
However, the expression of MBL-A and MBL-C in bronchiolar epithelium and 
alveolar wall before, during and after pregnancy was not detected. 
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Figure 4.5. Spatial expression of lectins in maternal lung. H&E and 
immunostaining of lectins in maternal lungs in mice before (left panel), during 
(middle panel) and after (right panel) pregnancy are shown. Bronchiolar 
epithelium (in red arrows) or alveolar wall (in blue arrows) positively stained with 
Ficolin-A and Ficolin-B are indicated. Images are at 200x magnification, aw: 
alveolar wall; be: bronchiolar epithelium. n=2, the representing sections from NP, 
El2.5 and PO are presented. 
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4.4 Discussion 
In Western and immunohistochemical analyses, MBLs and Ficolins were 
expressed in maternal livers and lungs. This is consistent with previous report that 
MBLs and Ficolins were expressed in liver and lung in healthy subjects (Wagner S 
et al., 2003). Expression levels of lectins in maternal livers were higher than in 
maternal lungs. Particular in immunohistochemistry, expression levels of Ficolins 
were higher than that of MBLs, with a higher expression of Ficolin-B than Ficolin-A 
and higher expression of MBL-C than MBL-A. These differential expressions of 
members of lectins suggest that the activation of innate immunity during normal 
pregnancy is rather selective, predominantly Ficolin-B and MBL-C in maternal liver. 
Expression levels of lectins in maternal livers and lungs did not change 
significantly throughout pregnancy with reference to their levels before pregnancy. 
It suggests that lectins in maternal livers and lungs are not activated in pregnancy 
and innate immunity during pregnancy is not maternal liver and lungs dependent. 
Expressions of Ficolins in maternal livers and lungs were increased only after 
delivery. After delivery, postpartum women enter period of puerperium for which 
the pelvic organs return to their pre-pregnant condition. It involves physiological 
changes in involution of generative uterus, recovery of endometrium, and 
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preparation of breast for lactation. The postpartum activation of lectins, particular 
Ficolin-B in maternal liver and lung, has never been reported. Its contributions to 
the maternal humoral innate immunity after delivery open up an interesting area for 
further studies in puerperium physiology. 
Slightly fatty change was observed in maternal liver during pregnancy. This 
should be a normal physiological change for the increasing nutrients storage during 
pregnancy (Everson, 1998), but the fatty change in maternal liver did not 
significantly affect the immunoreactivity of anti-mouse lectin antibodies in 
immunohistochemistry analysis. Ficolins were mainly expressed in both 
hepatocyte and bile duct epithelium, whilst MBLs were only expressed in 
hepatocytes, but not bile duct. Interestingly, the distribution of lectins in maternal 
liver changes along the gestation, from inccentric before pregnancy, eccentric during 
pregnancy to pan-hepatic expression after pregnancy. The role of ficolins and 
MBLs in different cell type and region in maternal liver requires further functional 
evaluation. 
4.5 Conclusion 
Lectins, particular Ficolin-B and MBL-C, were expressed in maternal livers 
4 0 
and lungs. Their expression levels were maintained before and during pregnancy, 
but increased only after delivery. 
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Chapter 5 
Pattern recognition lectins in endometrium 
5.1 Introduction 
Endometrium is the lining of uterus and also bedding for embryo, the site of 
pregnancy. Before pregnancy, endometrium proliferates under the influence of 
follicle-stimulating hormone (FSH) and luteinizing hormone (LH) stimulation after 
ovulation to prepare implantation of embryo. In early pregnancy, endometrium 
undergoes decidualization, a process by which extensive remodeling events in 
glandular epithelium and uterine arteriole take place, to ensure proper placental 
development and embryo growth. Pregnancy is an immune challenge and immune 
defence in endometrium is important for the success of implantation in early 
pregnancy (King et al., 2003). There is very little information on the expression of 
pattern recognition lectins, the humoral molecules of innate immunity, in 
endometrium and their role in pregnancy. Here the expression of pattern 
recognition lectins in endometrium before, during and after pregnancy was 
investigated. 
As it is practically and ethically not possible to obtain endometrium biopsy 
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from healthy human pregnancy, mouse was used as a model in this part of study. 
Uterus were collected from mice at early gestational stages of pregnancy. The 
uterus before and after pregnancy were also collected for analysis. It is difficult to 
separate pure endometrium layer from the uterus for protein isolation and lectin 
content study. Mainly, immunohistochemistry using antibodies against lectins were 
employed to characterize the spatial expression of lectins in endometrium in this 
chapter. 
5.2 Materials and Methods 
5.2.1 Animals 
Female ICR mice supplied by LASEC were used for the study. Non-pregnant 
adult ICR, pregnant mice at embryonic day 2 to 18 (E2 to El 8) and postpartum mice 
at day 0 to 7 (PO to P7) were obtained. Overnight mating was performed and 
vaginal plug was checked in the next morning for successful mating. Fertilization 
at midnight was assumed and regarded as embryonic day 0 (EO). The mice were 
sacrificed and non-pregnant, early pregnant (E2 and E5) and postpartum (PO) uterus 





























































































































Uterus collected at different stages were fixed in 4% paraformaldehyde solution 
at 4 overnight. Tissues, including outer myometrium and inner endometrium 
layers of the uterus, were processed, embedded and cut into five-|im-thick tissue 
sections. Tissue sections were stained with H&E for histological examination. 
Other sections were immunostained with rabbit anti-mouse Ficolin-A (1:100 
dilution), rabbit anti-mouse Ficolin-B (1:100 dilution), rat anti-mouse MBL-A 
(1:200 dilution) or rat anti-mouse MBL-C (1:200 dilution) primary antibody for 
immunohistochemical analysis following standard protocol mentioned in previous 
chapter. Histological sections were examined using Leica microscope. 
5.3 Results 
Figure 5.2 showed the histology and immunoshistochemistry of lectins of 
endometrium in mice before, during early pregnancy and after pregnancy with the 
structures of uterine gland, stromal and decidual cells. Enlargement of uterine 
gland was observed in early pregnancy at E2, but glands were shrunken in early 
decidualization after implantation of embryo at E5. The extended glandular 
epithelium was recovered in multivillous shape after delivery. 
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Ficolin-A and Ficolin-B were positively stained mainly in glandular epithelium 
and stroma respectively, and their expression was higher during early pregnancy and 
postpartum state than in non-pregnancy. Ficolin-A and Ficolin-B were also 
localized in the implantation site and associated decidual tissues in early pregnancy 
at E5. 
MBL-A and MBL-C were not expressed in either stroma or glandular 
epithelium in non-pregnancy, early pregnancy and postpartum. 
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Figure 5.2. Spatial expression of lectins in endometrium. H&E and 
immunostaining of lectins in endometrium in mice before pregnancy (left panel), in 
early pregnancy (E2 and E5, middle panel) and after pregnancy (PO, right panel) are 
shown. Stroma (in red arrows), glandular epithelium (in blue arrows), or decidua 
(in black arrows) positively stained with Ficolin-A and Ficolin-B are indicated. 
n=2, the representing sections from each gestation are presented. Images of 
non-pregnancy state are at 400x magnification while the others are at 200x 
magnification, g: glandular epithelium; s: stroma; m: myometrium; d: decidua. 
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5.4 Discussion 
In non-pregnancy state, Ficolin-A and Ficolin-B were expressed in 
endometrium. Being pattern recognition lectins that can recognize pathogens and 
promote phagocytotic activities, ficolins in endometrium might contribute to the 
local uterine defence of the female reproductive tract. Its functional roles in 
protecting the uterus from infections and preparing physiological endometrium 
changes in menstrual cycle require further characterizations. 
During early pregnancy, the expression levels of both FicolinA and Ficolin-B in 
endometrium were increased. Ficolin-A was mainly localized in endometrial 
glandular epithelium, while Ficolin-B was mainly localized in stroma. This 
differential expression of ficolins suggests the two ficolin isoforms might have 
different biological roles and molecular functions in the innate immune defence in 
the endometrium during pregnancy. 
Glandular epithelium is the lining of endometrium in direct contact with 
external environment and growing embryo. It is the first line defence structure in 
female reproductive tract. In addition, endometrial glands are important for 
implantation and placentation by secreting rich nutrients and growth factors that are 
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essentia丨 for placental development (Burton et al., 2007). Stroma is the core of 
endometrium underneath the glandular epithelium. It not only contains connective 
tissue and matrix structure, but also immune cells for immunological signaling and 
inflammatory response for infection and pregnancy. Specificity of Ficolin-A in 
glandular epithelium may be responsible for the defence of female reproductive 
lining, and Ficolin-B in stroma may contribute to the immune response for embryo 
implantation. This change in early pregnancy was specific in endometrium, the site 
of implantation and suggests ficolins might play a role in pregnancy success and 
implantation preparation during early pregnancy. 
In contrast with maternal livers and lungs where expression levels of ficolins 
did not change during pregnancy, the expression levels of ficolins in endometrium 
were higher in early and after pregnancy than in non-pregnancy. This indicates that 
expressions of lectins in endometrium were not associated with maternal liver or 
lung during pregnancy and might contribute the local innate immunity during 
pregnancy. 
After delivery, postpartum endometrium maintained its high Ficolin-A and 
Ficolin-B expressions in glandular epithelium and stroma, respectively. This 
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suggests ficolins might have a role in endometrial recovery after delivery. 
Both MBL-A and MBL-C were not expressed in endometrium in 
non-pregnancy state, during pregnancy and after delivery. It suggest that MBLs are 
not involved in the innate lectin pathway for uterine defence, early implantation nor 
endometrial recovery. 
5.5 Conclusion 
Ficolins, but not MBLs, were expressed in mice endometrium in early 
pregnancy, before and after pregnancy. Ficolin-A was specific in glandular 
epithelium and Ficolin-B was specific in stroma of endometrium. Their 
expressions in endometrium were increased in early pregnancy. 
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Chapter 6 
Pattern recognition lectins in maternal-fetal 
interface 
6.1 Introduction 
In pregnancy, the mother physically, physiologically and immunologically 
interacts with the fetus in the maternal-fetal interface. Direct contact of fetal 
trophoblasts with maternal uterine tissues is involved in implantation and 
placentation. During implantation, trophoblast of the blastocyst adheres to and 
penetrates the uterine wall; and placentation begins. Extravillous trophoblasts 
invade into and migrate through the decidua, interacting with all kinds of maternal 
cells including immune cells (Moffett-King, 2002). Some extravillous trophoblasts 
invade and transform uterine spiral arteries to ensure an adequate uteroplacental 
circulation for embryo growth (Kaufmann et al., 2003). 
At the end of the first trimester, maternal blood starts to flow into the intervillous 
space of the placenta where maternal blood and immune cells come into contact 
with the fetal syncytiotrophoblasts (Jauniaux et al., 2000). There are numerous 
interactions between maternal and fetal cells throughout pregnancy. Interactions 
51 
must be tightly controlled for pregnancy success and maintenance. 
In this chapter, expression of lectins in the maternal-fetal interface in normal 
pregnancy was studied. As it is practically and ethically not possible to obtain 
maternal-fetal tissue from healthy human pregnancy again, mouse was used as a 
model in this part of study. Uterus containing developing placenta were collected 
from mice at different stages of pregnancy. In order to characterize the expression 
of lectins in individual component in maternal-fetal interface which shows tissue 
heterogeneity from mixed origin, immunohistochemistry using specific antibodies 
against lectins was employed to characterize the spatial expression of lectins in the 
maternal-fetal interface. 
6.2 Materials and Methods 
6.2.1 Animals 
Female ICR mice supplied by LASEC were used for the study. Pregnant ICR 
mice at embryonic day 2 to 18 (E2 to El8) were included. Overnight mating was 
performed and vaginal plug was checked the next morning for successful mating. 
Fertilization at midnight was assumed and regarded as embryonic day 0 (EO). The 
mice were sacrificed, and maternal uterus were collected. To maintain the 
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maternal-fetal interface, placentae were retained inside the uterus. In advanced 


















































































































































Maternal uterus containing placentae at different stages of pregnancy were 
fixed in 4% paraformaldehyde solution at 4 overnight. Tissues were processed, 
embedded and cut into five-^m-thick tissue sections. Tissue sections were stained 
with H&E for histological examination. Other sections were also immunostained 
with rabbit anti-mouse Ficolin-A (1:100 dilution), rabbit anti-mouse Ficolin-B 
(1:100 dilution), rat anti-mouse MBL-A (1:200 dilution) or rat anti-mouse MBL-C 
(1:200 dilution) primary antibody for immunohistochemical analysis following 
standard protocol mentioned in previous chapter. Histological sections were 
examined under Leica microscope. 
6.3 Results 
Figure 6.2 showed the histology and immunohistochemistry of lectins of 
maternal-fetal interface in mice in early (E6), mid- (E8) and late pregnancy (El5). 
Histology of early gastrulate embryo and early decidua in gestation at E6, and late 
gastrulate embryo, decidua parietalis and decidua basalis in gestation at E8 were 
observed. In late gestation at El 5, trophoblast cells in developing placenta and 
decidual cells in decidua basalis were examined. 
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In early decidualization at E6, Ficolin-A and Ficolin-B were localized in 
decidual cells but not in trophoblastic cells; while MBL-A and MBL-C were not 
expressed in either decidual cells or trophoblastic cells at this early gestational stage. 
In late decidualization and early placentation at E8, Ficolin-A and Ficolin-B 
were expressed in trophoblast giant cells in decidua parietal is, but not in 
trophoblastic cells in ectoplacental cone; and in decidual cells in decidua basalis. 
Maternal blood cells were also positively stained around the developing embryo. 
MBL-A and MBL-C were not detected in either decidual cell or trophoblastic cells, 
but expressed in maternal blood cells only at this stage. 
In late placentation at El5, trophoblastic cells in placenta and decidual cells in 
decidua basalis were positively stained with Ficolin-A and Ficolin-B antibodies. 
Maternal blood cells were positively stained in decidua basalis only with Ficolin-B 
antibody, but not with MBL antibodies. 
The expression levels of ficolins and MBLs in maternal-fetal interface were 
higher in mid-pregnancy than in early and late pregnancy. 
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Figure 6.2. Spatial expression of lectins in maternal-fetal interface. H&E and 
immunostaining of lectins in maternal-fetal interface in mice in early (E6, left panel), 
mid- (E8, decidua parietalis and decidua basalis, middle panel) and late pregnancy 
(El5, placenta and decidua basalis, right panel) are shown. Decidual cells (in blue 
arrows), trophoblasts (in black arrows), and maternal blood cells (in red arrows) 
positively stained with Ficolin-A, Ficolin-B, MBL-A and MBL-C are indicated. 
Images of early pregnancy at E6 were at 400x magnification while the others were at 
200x magnification, db: decidua basalis; dc: decidual cells; e: embryo; epc: 
ectoplacental cone; mb: maternal blood; tc: trophoblastic cells. 
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6.4 Discussion 
As in endometrium, expressions of lectins in maternal-fetal interface were 
mainly contributed by ficolins, but not by MBLs. The only MBL-A and MBL-C 
expressions were found in maternal blood pools surrounding the developing embryo 
around the ectoplacental cone and decidual basalis in mid-pregnancy at E8. It 
indicates MBLs are not the major intrinsic lectins contributing to the humoral innate 
immunity in the endometrium and the maternal-fetal interface, but the extrinsic 
lectins distributing from the activated humoral innate immunity in maternal 
circulation. 
Ficolin-A and Ficolin-B were positively stained in decidual cells throughout the 
gestation and were stained in trophoblastic cells not in early gestation but in mi el-
and late gestations. The only involved trophoblastic cell type was spiral 
artery-associated trophoblast giant cells in decidua parietal is but not trophoblast in 
ectoplacental cone nor parietal trophoblast giant cells in decidual basalis in 
mid-pregnancy at E8. Trophoblastic cells and decidual cells are two important 
components of the maternal-fetal interface for normal placental development 
involved in trophoblast invasion and uterine remodeling in decidual parietal is (Cross 
et al., 2002; Hemberger, 2008). The expression of ficolins in these cells suggests 
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their important roles in establishing maternal and fetal interaction in decidualization 
and placentation. 
Limitation of the study is that tissue sections were not stained with human 
chorionic gonadotropin or human placental lactogen, and vimentin which are 
specific markers for trophoblast cell and decidual cell respectively to characterize 
the cell type from mixed origin at the maternal-fetal interface. 
6.5 Conclusion 
MBL-A and MBL-C were mainly expressed in maternal blood pools 
surrounding the developing embryo. Ficolin-A and Ficolin-B were localized 




Pattern recognition lectins in preeclampsia 
7.1 Introduction 
Preeclampsia is the most common and severe pregnancy complication of the 
second half of pregnancy (Kopcow and Karumanchi, 2007). It occurs in about 
three to five percent of all pregnancies and it is a major cause of maternal and fetal 
morbidity and mortality. Preeclampsia is characterized by new onset of 
hypertension and proteinuria, and it is commonly associated with edema and 
hyperuricemia (Baumwell and Karumanchi, 2007). Placenta plays a main role in 
the pathogenesis of preeclampsia and removal of placenta rapidly resolves clinical 
manifestation in preeclampsia. 
Suggested etiology of preeclampsia includes endothelial dysfunction, poor 
angiogenesis, excessive maternal inflammation and poor placentation (Roberts et al., 
1989; Redman, 1992; Redman et al., 1999). Maladaptation of maternal immune 
responses was also associated with preeclampsia (Dekker and Sibai, 1999). 
Two members of innate immunity, TLR-4 protein and macrophage migration 
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inhibitory factor (MIF), have been shown to be increased in preeclampsia (Kim et al., 
2005; Todros et al., 2005). Though no significant difference was found in serum 
MBL concentration between preeclamptic couples and control groups, plasma 
concentrations of H-ficolin and L-ficolin were found significantly altered in our 
previous proteomic study in preeclampsia (Kilpatrick, 1996; Wang et al., 2007). 
These suggested the selective innate immune system was involved in the 
pathophysiology of preeclampsia. As stated, placenta is the key pathology of 
preeclampsia. The innate immune molecules in preeclamptic placenta have not 
been examined. In our animal studies in previous chapters, innate pattern 
recognition lectins are involved in the early and late placentation during normal 
pregnancy. Its expression in preeclamptic placenta remains largely unclear, 
however. 
In this chapter, expression of pattern recognition lectins (human H-ficolin and 
L-ficolin) in preeclamptic placenta; and their possible roles in the pathophysiology 
of preeclampsia were studied. 
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7.2 Materials and Methods 
7.2.1 Patients 
Pregnant women having antenatal check-ups at the Department of Obstetrics 
and Gynaecology at the Prince of Wales Hospital were recruited with written and 
informed consent. Ethics approval was obtained from the Research Ethics 
Committee of the University. The gestational age was validated by early 
ultrasound examination and only singlet pregnancies were included. 
Preeclampsia was diagnosed when there was newly identified hypertension and 
significant proteinuria in pregnant women without history of preexisting or chronic 
hypertension. A sustained rise in diastolic blood pressure to 110 mmHg or more on 
one occasion or at least 90 mmHg on two or more occasions at least four hours apart 
was regarded as hypertension, while significant proteinuria was considered to be 
present when proteinuria is higher than 0.3 g/day or at least ++ in two clean-catch 
midstream urine samples on two individual dipstick tests at least four hours apart 
(Davey and MacGillivray, 1988). 
Placental tissues were collected from preeclamptic and control pregnant women 
at delivery. Pregnant women without medical and antenatal complications through 
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pregnancy and postpartum periods were recruited as control. The placentae in two 
groups were matched by gestational age in sample collection. 
7.2.2 Protein extraction 
Human placental tissues were collected and thoroughly washed in IX PBS to 
remove maternal and fetal blood, snap frozen in liquid nitrogen and stored at -80 
until used. Each sample was lysed and homogenized in lysis buffer (50mM 
Tris-HCl, 300 mM NaCl, 1 mM PMSF, 1 mM EDTA, ImM DTT). Lysate was 
then centrifuged at 14000 rpm for 10 min at 4 and supernatant was transferred 
into a clean tube. Total protein concentration in supernatant was measured using 
DC protein assay kit. 
7.2.3 Western Blot 
100 |a.g total protein of lysate from each placental sample was mixed with 3X 
Laemmli loading dye and boiled at 95 for 5 min. Samples were then subjected 
to 12% SDS-PAGE and transferred onto nitrocellulose membranes following 
standard Western blot protocol. Broad range prestained SDS-PAGE standards was 
run on the same gel as a reference for the protein size. The membranes were 
blocked with ovalbumin in IX TBS at 37 overnight. The membranes were then 
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incubated with mouse anti-human H-Ficolin (clone 4H5; 1:1000 dilution; Hycult 
Biotechnology, Uden) or mouse anti-human L-ficolin (clone 2F5; 1:1000 dilution; 
Tokai University, Japan) primary antibody diluted in blocking solution at 37 for 
60 min. Polyclonal rabbit anti-mouse immunoglobulins HRP (Dako, Glostrup) 
was used as secondary antibody. The secondary antibody was diluted 1:1000 in IX 
TBS and incubated for 30 min at RT. The membranes were incubated with ECL™ 
Western blotting detection reagents and imaged with the Quantitiy One® 
quantification software (Bio-rad Laboratories, California). Protein expression was 
normalized with Actin expression (Santa Cruz Biotechnology Inc., CA). 
7.2.4 Lectin immunohistochemistry 
Placental tissues collected from both controls and preeclampsia patients were 
fixed in 4 % paraformaldehyde solution at 4 overnight. Tissues were processed, 
embedded and cut into five-|im-thick tissue sections. Sections were deparaffinized 
in xylene and rehydrated to distilled water. Tissue sections were stained with 
haematoxylin and eosin (H&E) for histological examination. In addition, sections 
were stained with mouse anti-human H-Ficolin (clone 4H5; 1:150 dilution; Hycult 
Biotechnology, Uden), mouse anti-human L-ficolin (clone 2F5; 1:500 dilution; 
Tokai University, Japan) or rabbit anti-human Fas (clone N18; 1:100 dilution; Santa 
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Cruz Biotechnology Inc., CA) primary antibody for immunohistochemical analysis. 
In IHC, sections were then undergone procedures for antigen retrieval, blocking 
endogeneous peroxidase and blocking as mentioned in previous chapter. Sections 
were then incubated with individual primary antibody diluted in blocking solution at 
4 overnight. Sections incubated with blocking solution with no primary 
antibody were used as negative control. After incubating with primary antibodies, 
sections were washed with IX PBS at RT, followed by secondary antibodies 
incubation. For the two ficolin primary antibodies, MACH 3 mouse HRP polymer 
kit (Biocare medical, Concord) was used as secondary antibody; while for anti-Fas 
antibody, MACH 3 rabbit HRP polymer kit was used. After incubating with 
secondary antibodies at RT, sections were washed with IX PBS and undergone 
colour development with Cardassian DAB Chromogen Kit (Biocare medical, 
Concord) at RT. Sections were then counterstained with 1% methyl green solution. 
Sections were dehydrated and mounted with DPX mounting medium. Histological 
sections were examined under Leica microscope. 
7.2.5 Apoptosis immunohistochemistry 
Apoptosis membrance protein, Fas, was used as apoptosis marker in PET 
placenta. A two-colour, double staining was also performed using mouse 
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anti-human H-ficolin and rabbit anti-human Fas antibody or mouse anti-human 
L-ficolin and rabbit anti-human Fas antibody. Steps followed standard 
immunohistochemistry protocol, but the two primary antibodies (H-ficolin/Fas or 
L-ficolin/Fas) were applied together onto the sections, incubating at 4 overnight. 
Double stain polymer detection kit #2 (mouse-HRP + rabbit-ALP) were used as the 
secondary antibody (Biocare medical, Concord). First colour development was 
done using Cardassian DAB Chromogen Kit (Biocare medical, Concord) at RT. 
Second stain was then performed using Vulcan Fast Red Chromogen Kit (Biocare 
medical, Concord) at RT. After colour development, sections were counterstained 
with 1 % methyl green solution and dehydrated. Sections were mounted with DPX 
mounting medium and were examined under Leica microscope. 
7.3 Results 
Demographic characteristics and obstetric outcomes of patients were 
summarized in Table 7.1. There was no significant difference is maternal age, 
height, body weight before pregnancy, gravidity, nulliparity, platelet count, and 
infant sex between the control and the preeclamptic women. Maximum systolic 
and diastolic blood pressure at delivery, and proteinuria were significantly higher in 
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preeclamptic women; while gestational age at delivery and birth weight were 
significantly lower. Less normal spontaneous delivery was found in preeclamptic 
women. 
Control Preeclampsia Significance 
Number of cases 11 11 -
Age (years old) 29.18土3.57 31.55+5.54 N.S. 
Maternal height (cm) 157.59±0.08 1 59.32±0.06 N.S. 
Body weight before pregnancy (kg) 50.5219.03 58.78112.06 N.S. 
Gravidity 1.9110.79 2.3±0.82 N.S. 
Null ipari ty 5/11 (45.45) 5 / 1 0 ( 5 0 ) N.S. 
Max sbp (mmHg) 118.45+10.91 173.09+13.91 S. 
Max dbp (mmHg) 70.8217.56 103.18±12.26 S. 
Proteinuria (number of positive sign) 0±0 2.91±0.87 S. 
Gestational at delivery (week) 39.94±1.39 36.16+3.44 S. 
Platelet count (x 10E9/L) 227.89±45.72 180.82±66.63 N.S. 
Normal Spontaneous Delievey (NSD) 8/11 (72.73) 2/11 (18.18) S. 
Sex of infant (Male) 6/10(60) 7/11 (63.64) N.S. 
Birth weight (kg) 3.16+0.35 2.26±0.75 S. 
Table 7.1. Demographic characteristics and obstetric outcomes of preeclamptic 
patients. Data presented are mean土sd or proportion (%). N.S.: No significance. 
S.: Significance. 
7.3.1 Expression levels of ficolins in normal and preeclamptic 
placenta 
H-ficolin (34 kDa) and L-ficolin (35 kDa) were expressed in placental lysate 
from both normal and established preeclamptic pregnancy, but their expression 
levels were higher in preeclamptic placenta than in normal pregnancy. The 
expression level of L-ficolin was higher than that of H-ficolin in preeclamptic 
placenta (Figure 7.1). 
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Figure 7.1. Expression of H-ficolin and L-ficolin in placental lysate in normal 
and preeclamptic pregnancy by Western blot analysis. n=5, 2 preeclampsia and 
1 control cases are presented. 
7.3.2 Spatial expression of ficolins in normal and preeclamptic 
placenta 
Syncytiotrophoblasts of the human placental tissues from both normal and 
established preeclamptic pregnancy were positively stained with anti-H-ficolin and 
anti-L-ficolin antibodies, but the expression levels of H-ficolin and L-ficolin were 
much higher in preeclamptic placenta than in normal placenta (Figure 7.2). 
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Figure 7.2. Spatial expression of lectins in placenta. Immunostaining of lectins 
in normal placenta (left panel) and preeclamptic placenta (right panel) are shown. 
Syncytiotrophoblasts (in blue arrows) positively stained with H-ficolin and L-ficolin 
are indicated. n=5, the representing sections are presented. Images are at 400x 
magnification. 
7.3.3 Co-localization of Fas and ficolins in preeclamptic placenta 
Excessive apoptosis in placenta has been associated with preeclampsia. 
Increased apoptotic protein Fas are the key molecules triggering the apoptosis in 
trophoblasts of preeclamptic placenta (Allaire et al., 2000). Apoptotic cells can 
induce lectin-complement pathway and be removed by phagocytosis. It is unclear 
if the excessive apoptosis in preeclamptic placenta is associated with the increased 
ficolins. 
6 9 
We performed double immunostaining of H-/L-ficolin and Fas in control and 
preeclamptic placenta. In Fas immunostaining, the expression of Fas was localized 
in syncytiotrophoblast cells. As in previous report, the expression level of Fas was 
much higher in preeclamptic placenta than in normal placenta. In our double 
immunostaining, H-ficolin and L-ficolin proteins were coexpressed with Fas protein 
in syncytiotrophoblasts and the co-expression was higher in preeclamptic placenta 
than in normal placenta. Higher number of apoptotic bodies in most of the ficolin-
and Fas- coexpressed syncytiotrophoblasts was observed in preeclamptic placenta 
(Figure 7.3). 
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Figure 7.3. Spatial expression of Fas and lectins in placenta. Immunostaining 
of Fas and, double staining of Fas and lectins in normal placenta (left panel) and 
preeclamptic placenta (right panel) are shown. Syncytiotrophoblasts (in blue 
arrows) positively stained with Fas or, Fas and ficolins are indicated. n=5, the 
representing sections are presented. Images are at 400x magnification. 
7.4 Discussion 
In Western blot analysis, the expression level of ficolins in placental lysate was 
much higher in preeclamptic placenta when compared to that in normal placenta. 
This is consistent with the immunohistochemical analysis, where the expression 
level of ficolins in syncytiotrophoblasts of the placenta was much higher in 
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preeclampsia than in normal pregnancy. Ficolins, as the pattern recognition 
molecules, can initiate innate immune responses by complement activation via the 
lectin pathway. The increased ficolin expression in preeclamptic placenta suggests 
the lectin involvement in the pathophysiology of preeclampsia, 
Placental development requires proper collaboration between maternal immune 
cells and fetal trophoblasts. Preeclampsia is characterized by insufficient 
trophoblast invasion in early decidualization and placentation that leads to poor 
remodeling of maternal spiral artery and restricted uteroplacental circulation for 
normal placental and fetal development (Harrington et al., 1996; Zhou et al” 1997). 
The excessive apoptosis in preeclamptic placenta, as evident by increased 
expression of Fas in syncytiotrophoblasts in preeclamptic placenta as in previous 
report, is the consequence of the insufficient uteroplacental circulation in 
placentation (Allaire et al., 2000). Ficolins are able to recognize and bind to 
apoptotic cells. Through binding to the apoptotic trophoblasts in preeclamptic 
placenta, as evident by the coexpression of ficolins and Fas in syncytiotrophoblasts, 
ficolins may participate in the clearance of the trophoblastic cells undergoing 
excessive apoptosis in preeclamptic placenta. 
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Interestingly, ficolin levels in maternal circulation, however, were found to be 
significantly lower in preeclampsia patients in our previous study. In the present 
study, the expression levels of ficolins in preeclamptic placenta were higher than 
that in normal pregnancy. The increase in ficolins expression in preeclamptic 
placenta might be associated with the decrease in plasma level by recruiting ficolins 
from the maternal circulation to the placenta. 
The innate immune responses mediated by increased ficolins in preeclamptic 
placenta have been further demonstrated by our colleague using cytokine antibody 
array (Wang et al., 2007). The pro-inflammatory chemokines and cytokines 
involved in innate immunity were shown to be significantly activated in both 
placenta and plasma from preeclampsia patients and associated with the severity of 
increased blood pressure, the hallmark of clinical manifestation of clinical 
preeclampsia. This further confirms the lectin involvement of preeclampsia 
through the lectin pathway, mainly by ficolins, contributing the aggressive local 
(placental) and systemic (plasma) innate immune responses in preeclampsia. 
However, limitation of the study is that there is no information on lectin expression 
in decidua, the maternal part of the maternal-fetal interface. 
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Taken all together, we hypothesize that poor trophoblast invasion leads to 
insufficient activation of maternal immune cells for proper spiral artery remodeling 
and uteroplacental circulation establishment, and poor placentation is resulted in 
preeclampsia. Trophoblasts due to poor placentation undergo excessive apoptosis 
and lead to excessive binding of ficolins to apoptotic trophoblasts. This accounts 
for the activation of local innate immune system and deportation of debris into 
maternal circulation. Maternal systemic immune responses are also activated and 
play a role in endothelial dysfunction in preeclampsia (Figure 7.4). 
genetic conflicts? 
immune m^adaptation? 
Inhibit extravlllous weak decidual . . 
f l o c a l responses 
I i n i n u i n e • 
V ^ e s p o , 脱力：二一 
small uteroplacental . j ^ F 
circulation ‘ 
^ r p lacen ta l i schaemia free radicals & lipid peroxides 
f poor \ :• 、• 
fetal growth I placentation \ ： A trophoblast apoptosis . • 1 ficolins \ . 
retardation I Stage 1:6-18 wks W： t f . co l i n binding - i ^ i • : 
I ¥： • ^ I innats immuns cytokines : responses 
^ ^ endothelium 
syncytotrophobOst deportation _ ^ ^ ^ 丨 ? ^ 
^ fetal DNA&RNA Stage 11. ^U WKS 
Feto-Placental Unit Watern^l Circulation 
Figure 7.4. A hypothesis on the role of ficolins in preeclampsia. 
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7.5 Conclusion 
Ficolins and Fas were co-localized in syncytiotrophoblasts of the placenta from 
both normal pregnancy and preeclampsia. The co-expression levels of ficolins and 
Fas in preeclamptic placenta, however, were higher than that in normal pregnancy. 
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Chapter 8 
Pattern recognition lectins in miscarriage 
8.1 Introduction 
Miscarriage, also known as spontaneous abortion, refers to a naturally 
occurring pregnancy loss before week of gestation (Warren and Silver, 2008). 
Miscarriage is a common medical problem in early pregnancies and the rate of 
miscarriage is about 10 to 20 % of all pregnancies (Vejborg et al., 2007). 
Possible maternal causes of miscarriage include infections; uterine 
malformations; endocrine disorders like polycystic ovary syndrome; alcohol and 
tobacco use; while fetal causes of miscarriage include cytogenetic abnormalities 
such as trisomies or monosomy (Jakubowicz et al., 2002). In addition, maternal 
immune response may also play a role. Antiphospholipid syndrome (APS) which 
is an autoimmune disorder involving the production of antiphospholipid antibodies 
has been reported to cause miscarriage (Salmon and Girardi, 2008). 
Mice with deficiency in complement receptor 1-related gene/protein y (Crry), 
which is a complement regulatory molecule, have demonstrated complement 
7 6 
deposition at the maternal-fetal interface and pregnancy loss (Caucheteux et al., 
2003). Besides, recurrent miscarriage was associated with low maternal serum 
MBL concentration (Christiansen et al., 1999). Such deficiency may account for 
the abnormal innate immune defence against pathogens and thereby spontaneous 
abortion as consequence. 
Since immunological collaboration in maternal-fetal interface is the key 
success of early pregnancy, other studies suggested that a dysfunctional innate 
immune system may play a role in fetal loss. In our previous chapters, the innate 
immune lectins were found to be expressed in maternal-fetal interface during normal 
pregnancy. In this chapter, expression of pattern recognition lectins (MBL, 
H-ficolin and L-ficolin) in the maternal-fetal interface of miscarriage patients was 
investigated. 
8.2 Materials and Methods 
8.2.1 Patients 
Women admitted to the Department of Obstetrics and Gynaecology at the 
Prince of Wales Hospital suffering from inevitable miscarriage were recruited with 
written and informed consent. Ethics approval was obtained from the Research 
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Ethics Committee of the University. The gestational age was determined based on 
the date of the mother's last menstrual period. If the menstrual cycle was irregular, 
ultrasound of gestational sac was used to determine the gestational stage. Three 
millilitre maternal blood was collected in EDTA tube before and after medical or 
surgical treatment for other study. Placental tissues and decidual basal is were 
collected by dilation and curettage (D&C) procedure from both miscarriage patients. 
Healthy women with unwanted pregnancy undergoing surgically termination of 
pregnancy were recruited as control. The two groups were gestational 
age-matched. 
8.2.2 Immunohistochemistry 
Placental tissues and decidual basalis collected from both controls and 
miscarriage patients were washed with sterile IX PBS and fixed in 4 % 
paraformaldehyde solution at 4 overnight. Tissues were processed, embedded 
and cut into five-iam-thick tissue sections. Tissue sections were stained with H&E 
for histological examination. In addition, sections were stained with mouse 
anti-human H-Ficolin (1:150 dilution), mouse anti-human L-ficolin (1:500 dilution) 
or mouse anti-human MBL (clone 3E7; 1:100 dilution; Tokai University, Japan) 
primary antibody for immunohistochemical analysis following standard IHC 
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protocol. Sections incubated with blocking solution without primary antibody 
were used as negative control. MACH 3 mouse HRP polymer kit (Biocare medical, 
Concord) was used as secondary antibody. Colour development was performed 
using Cardassian DAB Chromogen Kit at RT. Sections were counterstained with 
1% methyl green solution. Sections were then dehydrated and mounted with DPX 
mounting medium. Histological sections were examined using Leica microscope. 
8.3 Results 
Demographic characteristics and obstetric history of patients were summarized 
in Table 8.1. There was no significance difference in maternal age, gestational age 
and previous history of miscarriage between control and miscarriage patients. 
Control Miscarriage Significance 
number of cases 13 17 -
Maternal age (years old) 29.7± 12.6 33.9土6.5 N.S. 
Gestational age (week) 10.0土 1.2 10.7±1.9 N.S. 
Previous history of miscarriage (times) 0土0 1 土0.8 N.S. 
Table 8.1. Demographic characteristics and obstetric history of miscarriage 
patients. Data presented are mean土sd. M.S.: No significance. 
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8.3.1 Spatial expression of lectins in normal placenta and placenta 
from miscarriage patients 
Syncytiotrophoblasts of the human placenta tissues were positively stained with 
H-ficolin, L-ficolin and MBL antibodies, and the lectin expression was much higher 
in placenta from miscarriage patients than that in control placenta from 
uncomplicated pregnancy (Figure 8.1A-E). The increased lectins in placenta from 
miscarriage patients were more obvious when miscarriage developed in early 
gestation than that in late gestation. The expression levels of H-ficolin, L-ficolin 
and MBL were similar. Normal placenta was not found and matched with placenta 
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Figure 8.1 A. Spatial expression of lectins in placenta at gestation week 8. H&E 
and immunostaining of lectins in normal placenta are shown. The representing 
areas of trophoblastic villi are presented. Images are at 400x magnification. 
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Figure 8.IB. Spatial expression of lectins in placenta at gestation week 9. H&E 
and immunostaining of lectins in normal placenta (left panel) and placenta from 
miscarriage patients (right panel) are shown. Syncytiotrophoblasts (in blue arrows) 
positively stained with H-ficolin, L-ficolin and MBL are indicated. The 
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Figure 8.1C. Spatial expression of lectins in placenta at gestation week 10. 
H&E and immunostaining of lectins in normal placenta are shown. The 
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Figure 8.ID. Spatial expression of lectins in placenta at gestation week 11. 
H&E and immunostaining of lectins in normal placenta (left panel) and placenta 
from miscarriage patients (right panel) are shown. Syncytiotrophoblasts (in blue 
arrows) positively stained with H-ficolin, L-ficolin and MBL are indicated. The 
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Figure 8.IE. Spatial expression of lectins in placenta at gestation week 12. 
H&E and immunostaining of lectins in normal placenta (left panel) and placenta 
from miscarriage patients (right panel) are shown. Syncytiotrophoblasts (in blue 
arrows) positively stained with H-ficolin, L-ficolin and MBL are indicated. The 
representing areas of trophoblastic villi are presented. Images are at 400x 
magnification. 
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8.3.2 Spatial expression of lectins in normal decidua and decidua 
from miscarriage patients 
Glandular epithelium and decidual cells of the human decidual tissues from 
normal pregnancy were weakly stained with H-ficolin, L-ficolin and MBL 
antibodies. The lectin expression levels were much higher in decidua from 
miscarriage patients than that in control decidua from uncomplicated pregnancy 
(Figure 8.2A-E). Unlike placenta, the increased lectin expressions in decidua with 
miscarriage were not associated with the gestation period complicated with the 
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Figure 8.2A. Spatial expression of lectins in decidua at gestation week 8. H&E 
and immunostaining of lectins in normal decidua (left panel) and decidua from 
miscarriage patients (right panel) are shown. Decidual cells (in blue arrows) and 
glandular epithelium (in red arrows) positively stained with H-ficolin, L-ficolin and 
MBL are indicated. The representing areas of decidua basalis are presented. 
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Figure 8.2B. Spatial expression of lectins in decidua at gestation week 9. H&E 
and immunostaining of lectins in normal decidua (left panel) and decidua from 
miscarriage patients (right panel) are shown. Decidual cells (in blue arrows) and 
glandular epithelium (in red arrows) positively stained with H-ficolin, L-ficolin and 
MBL are indicated. The representing areas of decidua basalis are presented. 




Figure 8.2C. Spatial expression of lectins in decidua at gestation week 10. 
H&E and immunostaining of lectins in normal decidua (left panel) and decidua from 
miscarriage patients (right panel) are shown. Decidual cells (in blue arrows) and 
glandular epithelium (in red arrows) positively stained with H-ficolin, L-ficolin and 
MBL are indicated. The representing areas of decidua basalis are presented. 
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Figure 8.2D. Spatial expression of lectins in decidua at gestation week 11. 
H&E and immunostaining of lectins in normal decidua (left panel) and decidua from 
miscarriage patients (right panel) are shown. Decidual cells (in blue arrows) and 
glandular epithelium (in red arrows) positively stained with H-ficolin, L-ficolin and 
MBL are indicated. The representing areas of decidua basal is are presented. 
Images are at 400x magnification. 
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Figure 8.2E. Spatial expression of lectins in decidua at gestation week 12. 
H&E and immunostaining of lectins in normal decidua (left panel) and decidua from 
miscarriage patients (right panel) are shown. Decidual cells (in blue arrows) and 
glandular epithelium (in red arrows) positively stained with H-ficolin, L-ficolin and 
MBL are indicated. The representing areas of decidua basalis are presented. 
Images are at 400x magnification. 91 
8.4 Discussion 
Lectins are humoral innate molecules that can facilitate phagocytosis and the 
removal of non-self pathogens. Increased lectin expressions in miscarriage tissues 
suggest an activated local innate immune response in miscarriage and support that 
inappropriate innate immune response might lead to rejection of the semi-allogeneic 
fetus and thereby pregnancy loss. However, phagocytosis and apoptosis were not 
investigated in this study. As karyotyping of the fetus was not performed, current 
study only provides information about the increased expression of pattern 
recognition lectins at the time of miscarriage. No conclusion could be drawn on 
whether the difference in the lectin expression is a cause of pregnancy loss or a 
result from miscarriage. 
Previous report showed that recurrent miscarriage was associated with low 
maternal serum MBL concentration (Christiansen et al., 1999). However, the 
changes of plasma lectin levels in miscarriage patients have not been measured to 
confirm the previous findings. If this is true, the decreased plasma lectins in 
maternal circulation and the increased trophoblastic lectins in placenta in both 
preeclampsia (previous chapter) and miscarriage (this chapter) suggested a common 
pattern recognition lectin activation in both conditions. Preeclampsia is a 
9 2 
complication of late pregnancy, whilst miscarriage is a complication of early 
pregnancy. Pathological findings in both complications suggested primary or 
secondary trophoblastic changes in the maternal-fetal interface. The link between 
these two common obstetric complications requires detail studies to understand the 
underlying mechanism in the development of the diseases. 
8.5 Conclusion 
Lectins were localized in syncytiotrophoblasts of placenta, and glandular 
epithelium and decidual cells of decidua. The expression level of lectins in placenta 




The expression of pattern recognition lectins in endometrium and 
matemal-fetal interface suggests their role in innate immunity for lining defence and 
for decidualization and placentation in normal pregnancy. Abnormal lectin 
expression in maternal-fetal interface was associated with abnormal pregnancies in 
preeclampsia and miscarriage. 
Gene polymorphisms in lectins and their susceptibility to uterine infection and 
abnormal pregnancy are still unknown. Genetic association studies are required to 
evaluate the role of lectins in uterine immune response and the development of 
pregnancy-associated disorders. In addition, lectins are associated with serine 
proteases and initiate innate immune responses via the lectin pathway. Further 
investigation in the molecular regulation of serine proteases and complement 
complexes involved in lectin pathway in normal and abnormal pregnancies is 
necessary to understand the disease mechanism. 
Preeclampsia, a late pregnancy complication, can be only detected in the 
9 4 
second half of pregnancy. The potential of ficolins as a predictive marker of 
preeclampsia requires further evaluation. In our miscarriage study, no recurrent 
miscarriage patient was included. Recurrent miscarriage patients are women with 
three or more consecutive spontaneous abortions which are highly related to 
abnormal immunological factors. Further characterization study and intervention 
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